J. B. Chemicals & Pharmaceuticals Limited
Simbolis: JBCHEPHARM.NS
NSE
1743.85
INRRinkos kaina šiandien
53.2431
P/E santykis
8.4545
PEG koeficientas
270.64B
MRK kapitalizacija
- 0.01%
DIV pajamingumas
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2928.6 | 566.5 | 6936.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 2159.3 | 1.1 | 6649.7 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 5771.7 | 6238.8 | 4186.7 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 4304.9 | 4099.6 | 3474.5 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 2275.1 | 1843.6 | 928.2 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 15280.3 | 12748.5 | 15526 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5764.2 | 5668.2 | 5696.6 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 574.6 | 574.6 | 574.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 13222.8 | 6713.9 | 321.1 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 13797.4 | 7288.5 | 895.6 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 137.8 | 127.2 | 129.1 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 65.1 | 64.3 | 69.4 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 493.9 | 177.2 | 64.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 20258.4 | 13325.5 | 6855.1 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 2386.4 | 2244.8 | 1869.2 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1739.1 | 339.4 | 398.5 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 49.5 | 60.9 | 79 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 3985.4 | 206.2 | 51.4 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | 152.1 | 31.7 | 49.3 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 236.5 | 88.2 | 99.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 5190.7 | 850.7 | 794.1 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 242.1 | 282.4 | 123.4 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 10735.2 | 4687.9 | 4246.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 154.8 | 154.6 | 154.6 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 22757.1 | 18427.1 | 15847.9 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2698.8 | 2248.4 | 1583.6 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -807.1 | 511.2 | 511.2 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 24803.5 | 21341.2 | 18097.2 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 44.9 | 37.1 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 24803.5 | 21386.1 | 18134.3 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 323.9 | 128.1 | 130.9 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 5724.5 | 545.6 | 449.9 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | 4955.2 | -19.9 | 163 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5552.3 | 5049 | 5968.9 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1146.7 | -1685.9 | 0 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 693.7 | 626.5 | 0 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -299.2 | -3025.2 | -942.1 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | -417.5 | -2928.4 | -706 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -205.2 | -625.1 | -700.9 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | 323.5 | 528.3 | 464.8 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 311.9 | 10.3 | -2565.6 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1998.6 | -7003.9 | -85 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -7568.7 | -5084.7 | -5412.1 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 5570.1 | 12088.6 | 3169.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -1968.4 | 7091.1 | 498.9 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -9617.9 | 23.2 | -2306.8 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -872.5 | -3.3 | -3.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 84.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 5684.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -1275.9 | -1275.6 | -732.4 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -55.8 | -105 | -138.6 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3565.4 | -1383.9 | -874.2 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.3 | 0 | 0.4 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 203.9 | 340.7 | -32.8 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 769.3 | 565.4 | 224.7 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 565.4 | 224.7 | 257.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 6256.1 | 1701.3 | 3147.8 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -1393.4 | -5366.5 | 2670.1 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 31492.8 | 24242.4 | 20058.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3842.2 | 8633.7 | 7174.4 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 27650.6 | 15608.7 | 12884.1 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 13997.4 | 10862.7 | 8009.7 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3842.2 | 19496.5 | 15184.1 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 25.4 | 9.3 | 17.7 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5917.9 | 4739 | 4895.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 27650.6 | 5049 | 5968.9 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 893.1 | 1188.6 | 1483.6 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 4098.3 | 3853.6 | 4479.6 |
Dažnai užduodami klausimai
Kas yra J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) bendras turtas?
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) bendras turtas yra 35538700000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.890.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 14.157.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.152.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.855.
Kas yra J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 4098300000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 5724500000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 13997400000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.